Dexmedetomidine versus Midazolam to shorten time on the ventilator in very preterm infants
Official title: Efficacy of Dexmedetomidine Versus Midazolam Sedation on Extubation Time in Mechanically Ventilated Preterm Infants: a Randomized Controlled Multicenter Trial - DEXPRE
Run by Assistance Publique - Hôpitaux de Paris · NCT06878703 · Data updated 2026-11-12
This trial will test whether using dexmedetomidine instead of midazolam helps very preterm infants on invasive mechanical ventilation be extubated sooner.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | Any age to 32 Weeks |
| Sex | All |
| Enrollment | 380 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | October 16, 2025 |
| Main results expected | December 30, 2027 |
| Study ends | October 16, 2029 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT06878703 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Very preterm neonates born before 32 weeks' gestation with corrected age under 45 weeks who require sedation for invasive mechanical ventilation and whose parents provide informed consent.
✕Probably not a fit
Infants with hemodynamic instability, recent extubation, receiving contraindicated medications (e.g., clonidine or curare), or other contraindications to dexmedetomidine or midazolam are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized phase 3 trial compares continuous intravenous dexmedetomidine infusion versus continuous intravenous midazolam infusion for sedation of very preterm neonates (<32 weeks gestation) who require invasive mechanical ventilation. Infants are randomized to receive a loading dose followed by a maintenance infusion within specified dose ranges for each drug while on ventilation, with care delivered in participating NICUs. The primary outcome centers on time to successful extubation and the protocol aims to enroll about 292 randomized patients (anticipating ~380 screened). Standard inclusion/exclusion and safety monitoring procedures are used to limit enrollment to clinically stable infants without contraindications to either agent.
Why it matters
Potential benefit: If successful, the dexmedetomidine arm could shorten duration of invasive ventilation and help reduce lung injury and rates of bronchopulmonary dysplasia by enabling earlier extubation.
How similar studies have gone: Small randomized and observational studies suggest dexmedetomidine is feasible and may cause less respiratory depression than benzodiazepines, but definitive phase 3 evidence in very preterm infants is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient admitted in NICU (intubated or not yet), * Gestational age at birth \< 32 weeks of gestation (WG), * Corrected gestational age \<45 weeks postmenstrual age Written or electronic informed consent signed by both parents. Randomization Criteria : * Indication for sedation in the context of invasive mechanical ventilation, * Patient intubated or not yet, * Elective sedation (acceptable delay between the decision to sedate and the administration of the sedative agent), * Presence or plan of a venous access, * No medical contraindication related to the administration of dexmedetomidine or midazolam, * No previous use of dexmedetomidine or midazolam within 48 hours, except for the sedation procedure for intubation, * No concomitant use of curare agent, * No clonidine treatment, * No previous extubation within 7 days, * No hemodynamic instability * No palliative care, Exclusion Criteria: * Patient admitted in NICU (intubated or not yet), * Gestational age at birth \< 32 weeks of gestation (WG), * Corrected gestational age \<45 weeks postmenstrual age Written or electronic informed consent signed by both parents.
Where it's running
-
Hospital Armand Trousseau, APHP Service : Department of Neonatology
Paris, France Recruiting
Study contacts
- Principal investigator: Clément CHOLLAT, Doctor — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Clément CHOLLAT, MD, PhD, Associate Professor
- Email: clement.chollat@aphp.fr
- Phone: +33 6 86 72 29 58
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Continuous body-temperature monitoring of preterm babies after birth using a wireless adhesive thermometer
This study tests whether a wireless, adhesive thermometer can continuously monitor temperature in preterm neonates during the first 15 minutes after birth.
-
Breathing patterns in preterm infants before and after extubation.
This will try to see if measuring work of breathing with soft chest and abdominal bands can predict which intubated premature infants (≤32 weeks) will tolerate removal of their breathing tube.
-
Minimizing radiation exposure in very preterm babies
This trial will try using bedside lung ultrasound instead of routine chest X-rays to guide breathing support for babies born before 32 weeks.
-
Using PEEP and EIT to keep lungs open in babies born before 32 weeks
This study tests whether adjusting gentle breathing pressure (PEEP) guided by electrical impedance tomography (EIT) helps keep the lungs open in babies born before 32 weeks who need CPAP or ventilator support.
-
Co-designed pain and sedation protocol for adults on ECMO
This project will test a co-designed pain and sedation plan to see if it's acceptable for adults receiving ECMO and similar ventilated ICU patients.
-
Heart rate variability and standard tests to help decide when to remove a breathing tube
This study will test whether combining heart rate variability from a wearable ECG sensor with standard weaning tests can help doctors decide when patients on mechanical ventilation are ready to have the breathing tube removed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.